Severe early-onset manifestations of pseudoxanthoma elasticum resulting from the cumulative effects of several deleterious mutations in ENPP1, ABCC6 and HBB: transient improvement in ectopic calcification with sodium thiosulfate.
Journal
The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
accepted:
17
10
2019
pubmed:
28
10
2019
medline:
15
5
2021
entrez:
25
10
2019
Statut:
ppublish
Résumé
Pseudoxanthoma elasticum (PXE) is a rare disorder characterized by fragmentation and progressive calcification of elastic fibres in connective tissues. Overlap has been reported between the inherited PXE phenotype associated with ENPP1, ABCC6 or NT5E mutations and acquired PXE clinical manifestations associated with haemoglobinopathies induced by HBB mutations. No treatment is currently available for PXE. A young boy presented with severe early-onset systemic calcifications occurring in the skin as elastosis perforans serpiginosa (EPS) and in the arteries, causing mesenteric and limb ischaemia. Analyses revealed deleterious ABCC6, ENPP1 and HBB mutations. The diagnosis of severe PXE was retained and we have coined the term 'PXE+ syndrome' to describe the cumulative effects of the various mutations in this uncommon phenotype. Given the severity, rapid progression and a potentially fatal prognosis, intravenous sodium thiosulfate (STS) was initiated at 25 g three times weekly for 6 months. Numerous side-effects prompted dosage adjustment to 10 g intravenously daily. Treatment efficacy was evaluated at 6 months. Asthaenia, anorexia and pre-/postprandial pain had subsided, entailing weight gain. Abdominal EPS had diminished. Calcific stenosis of the coeliac and mesenteric arteries was no longer detectable on arterial ultrasonography. Follow-up revealed only transient efficacy of STS. Discontinuation of treatment to evaluate the persistence of effects resulted in relapse of the initial symptomatology after 4 months. STS efficacy is conceivably due to strong antioxidant properties and chelation of calcium to form soluble calcium thiosulfate complexes. This case is suggestive of PXE+ syndrome for which STS may represent potential treatment in severe cases. What's already known about this topic? Generalized arterial calcification of infancy may occur in association with ABCC6 mutations and pseudoxanthoma elasticum (PXE) can be linked to ENPP1 mutations. A PXE-like phenotype has also been reported in a subset of patients with inherited haemoglobinopathies, namely sickle cell disease or β-thalassaemia, related to HBB mutations. To date, there is still no cure for PXE. What does this study add? We report a severe case of PXE resulting from the cumulative effects of several deleterious mutations in ENPP1, ABCC6 and HBB. We suggest the term 'PXE+ syndrome' to describe such patients. Sodium thiosulfate therapy could represent a potential option in severe cases of PXE+ syndrome.
Substances chimiques
ABCC6 protein, human
0
Multidrug Resistance-Associated Proteins
0
Thiosulfates
0
Phosphoric Diester Hydrolases
EC 3.1.4.-
ectonucleotide pyrophosphatase phosphodiesterase 1
EC 3.1.4.1
Pyrophosphatases
EC 3.6.1.-
sodium thiosulfate
HX1032V43M
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
367-372Informations de copyright
© 2019 British Association of Dermatologists.
Références
Lefthériotis G, Omarjee L, Le Saux O et al. The vascular phenotype in pseudoxanthoma elasticum and related disorders: contribution of a genetic disease to the understanding of vascular calcification. Front Genet 2013; 4:4.
Le Saux O, Urban Z, Tschuch C et al. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet 2000; 25:223-7.
Jansen RS, Küçükosmanoglu A, de Haas M et al. ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release. Proc Natl Acad Sci U S A 2013; 110:20206-11.
Jansen RS, Duijst S, Mahakena S et al. ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report. Arterioscler Thromb Vasc Biol 2014; 34:1985-9.
Rutsch F, Ruf N, Vaingankar S et al. Mutations in ENPP1 are associated with ‘idiopathic’ infantile arterial calcification. Nat Genet 2003; 34:379-81.
Nitschke Y, Rutsch F. Generalized arterial calcification of infancy and pseudoxanthoma elasticum: two sides of the same coin. Front Genet 2012; 3:302.
Devriese M, Legrand A, Courtois M-C et al. Pseudoxanthoma elasticum with prominent arterial calcifications evoking CD73 deficiency. Vasc Med 2019; 24:461-4.
Mitre V, Brown D, Phung T, Hunt RD. Classic pseudoxanthoma elasticum in a girl with sickle cell disease. Pediatr Dermatol 2019; 36:e64-5.
Fabbri E, Forni GL, Guerrini G, Borgna-Pignatti C. Pseudoxanthoma-elasticum-like syndrome and thalassemia: an update. Dermatol Online J 2009; 15:7.
Stella J, Buers I, van de Wetering K et al. Effects of different variants in the ENPP1 gene on the functional properties of ectonucleotide pyrophosphatase/phosphodiesterase family member 1. Hum Mutat 2016; 37:1190-201.
Uitto J, Jiang Q, Váradi A et al. Pseudoxanthoma elasticum: diagnostic features, classification and treatment options. Expert Opin Orphan Drugs 2014; 2:567-77.
Narayanan H, Cheng K, Lau K et al. Imaging manifestations of acquired elastopathy resembling pseudoxanthoma elasticum in patients with beta thalassaemia major and sickle cell disease. J Med Imaging Radiat Oncol 2016; 60:74-82.
Adam AM, Maritim MC. Pseudoxanthoma elasticum in a patient with sickle cell disease: case report. East Afr Med J 2008; 85:98-101.
Hamlin N, Beck K, Bacchelli B et al. Acquired pseudoxanthoma elasticum-like syndrome in beta-thalassaemia patients. Br J Haematol 2003; 122:852-4.
Martin L, Douet V, VanWart CM et al. A mouse model of β-thalassemia shows a liver-specific down-regulation of Abcc6 expression. Am J Pathol 2011; 178:774-83.
Aessopos A. Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes. Blood 2002; 99:30-5.
Tejero J, Stuehr D. Tetrahydrobiopterin in nitric oxide synthase. IUBMB Life 2013; 65:358-65.